{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:55:33Z","timestamp":1791665733714,"version":"4.3.4"},"reference-count":192,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,12,19]]},"DOI":"10.3233\/jad-170187","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T12:42:32Z","timestamp":1512132152000},"page":"487-508","source":"Crossref","is-referenced-by-count":21,"title":["Tauopathies: Mechanisms and Therapeutic Strategies"],"prefix":"10.1177","volume":"61","author":[{"given":"Chen-Chen","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170187_ref1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-130653","article-title":"Tauopathies and tau oligomers","volume":"37","author":"Takashima","year":"2013","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tcb.2014.07.005","article-title":"Connecting the dots between tau dysfunction and neurodegeneration","volume":"25","author":"Frost","year":"2014","journal-title":"Trends Cell Biol"},{"key":"10.3233\/JAD-170187_ref3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: Early progress and future directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170187_ref4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170187_ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/bse0560111","article-title":"The physiology and pathology of microtubule-associated protein tau","volume":"56","author":"Wang","year":"2014","journal-title":"Essays Biochem"},{"key":"10.3233\/JAD-170187_ref6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-associated protein tau in development, degeneration and protection of neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-170187_ref7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00401-013-1193-7","article-title":"Novel mutation in MAPT exon 13 (p. N410H) causes corticobasal degeneration","volume":"127","author":"Kouri","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-013-1229-z","article-title":"Neuropathological characterization of two siblings carrying the MAPT S305S mutation demonstrates features resembling argyrophilic grain disease","volume":"127","author":"Ronnback","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-013-1219-1","article-title":"The novel MAPT mutation K298E: Mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons","volume":"127","author":"Iovino","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref10","doi-asserted-by":"crossref","first-page":"e76409","DOI":"10.1371\/journal.pone.0076409","article-title":"A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function","volume":"8","author":"Iyer","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170187_ref11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.parkreldis.2013.04.023","article-title":"Pallidonigroluysian atrophy associated with p.\u00a0A152T variant in MAPT","volume":"19","author":"Graff-Radford","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-170187_ref12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/neup.12154","article-title":"Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques","volume":"35","author":"Ishida","year":"2015","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-170187_ref13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.15252\/embr.201541438","article-title":"Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice","volume":"17","author":"Maeda","year":"2016","journal-title":"EMBO Rep"},{"key":"10.3233\/JAD-170187_ref14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.0000000000003615","article-title":"Genome-wide association study identifies MAPT locus influencing human plasma tau levels","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-170187_ref15","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.neurobiolaging.2007.05.002","article-title":"Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus","volume":"29","author":"Caffrey","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170187_ref16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ng.2262","article-title":"Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome","volume":"44","author":"Koolen","year":"2012","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-170187_ref17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000440840","article-title":"Genetic disorders with tau pathology: A review of the literature and report of two patients with tauopathy and positive family histories","volume":"16","author":"Tacik","year":"2016","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-170187_ref18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12208","article-title":"Invited review: Neuropathology of tauopathies: Principles and practice","volume":"41","author":"Kovacs","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"Suppl 1","key":"10.3233\/JAD-170187_ref19","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.parkreldis.2015.09.020","article-title":"Tauopathies as clinicopathological entities","volume":"22","author":"Irwin","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-170187_ref20","unstructured":"Gao Y , Tan L , Yu JT , Tan L (2017) Tau in Alzheimer\u2019s disease: Mechanisms and therapeutic strategies. Curr Alzheimer Res, doi: 10.2174-1567205014666170417111859"},{"key":"10.3233\/JAD-170187_ref21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.01.028","article-title":"TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice","volume":"105","author":"Jiang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-170187_ref22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.3233\/JAD-170187_ref23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): A common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","article-title":"PART is part of Alzheimer disease","volume":"129","author":"Duyckaerts","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-015-0148-8","article-title":"Assessing clinicopathological correlation in chronic traumatic encephalopathy: Rationale and methods for the UNITE study","volume":"7","author":"Mez","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-170187_ref26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/alzrt234","article-title":"Chronic traumatic encephalopathy: A spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel","volume":"6","author":"Stein","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-170187_ref27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-170187_ref29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/BST0330595","article-title":"Clinicopathological features of the tauopathies","volume":"33","author":"Murray","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-170187_ref30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/psyg.12054","article-title":"Corticobasal degeneration initially developing motor versus non-motor symptoms: A comparative clinicopathological study","volume":"14","author":"Ikeda","year":"2014","journal-title":"Psychogeriatrics"},{"key":"10.3233\/JAD-170187_ref31","first-page":"513","article-title":"[Criteria for the diagnosis of corticobasal degeneration]","volume":"67","author":"Shimohata","year":"2015","journal-title":"Brain Nerve"},{"key":"10.3233\/JAD-170187_ref32","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/brain\/awr234","article-title":"Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome","volume":"134","author":"Kouri","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170187_ref34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170187_ref35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JAD-170187_ref36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mds.22977","article-title":"What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?","volume":"25","author":"Williams","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-170187_ref37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0304-3940(87)90204-7","article-title":"Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes","volume":"76","author":"Braak","year":"1987","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-170187_ref38","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/brain\/awm305","article-title":"Argyrophilic grain disease","volume":"131","author":"Ferrer","year":"2008","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref39","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.24559","article-title":"Deep clinical and neuropathological phenotyping of Pick\u2019s disease","volume":"79","author":"Irwin","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170187_ref40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2990.2012.01272.x","article-title":"Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: A study of the BrainNet Europe Consortium","volume":"39","author":"Kovacs","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-170187_ref41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","article-title":"Frontotemporal lobar degeneration: Defining phenotypic diversity through personalized medicine","volume":"129","author":"Irwin","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/978-1-4614-0653-2_23","article-title":"Pick\u2019s disease","volume":"724","author":"Takeda","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JAD-170187_ref43","doi-asserted-by":"crossref","first-page":"e0121570","DOI":"10.1371\/journal.pone.0121570","article-title":"A novel triple repeat mutant tau transgenic model that mimics aspects of pick\u2019s disease and fronto-temporal tauopathies","volume":"10","author":"Rockenstein","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170187_ref44","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/NEN.0000000000000248","article-title":"A novel tau mutation in Exon 12, p. Q336H, causes hereditary Pick disease","volume":"74","author":"Tacik","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-170187_ref45","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1021\/jm5017544","article-title":"Tau positron emission tomography (PET) imaging: Past, present, and future","volume":"58","author":"Ariza","year":"2015","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-170187_ref46","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/j.jalz.2014.04.013","article-title":"In vivo tau imaging: Obstacles and progress","volume":"10","author":"Villemagne","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170187_ref47","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/brain\/awu064","article-title":"Non-invasive assessment of Alzheimer\u2019s disease neurofibrillary pathology using 18F-THK5105 PET","volume":"137","author":"Okamura","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref48","doi-asserted-by":"crossref","first-page":"124192","DOI":"10.1155\/2015\/124192","article-title":"Novel PET\/SPECT probes for imaging of tau in Alzheimer\u2019s disease","volume":"2015","author":"Watanabe","year":"2015","journal-title":"ScientificWorldJournal"},{"key":"10.3233\/JAD-170187_ref49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11910-014-0500-6","article-title":"Tau PET imaging in Alzheimer\u2019s disease","volume":"14","author":"Okamura","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-170187_ref50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-130098","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808","volume":"38","author":"Chien","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref51","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/ml300216t","article-title":"Evaluation of [(11)C]N-methyl lansoprazole as a radiopharmaceutical for PET imaging of tau neurofibrillary tangles","volume":"3","author":"Shao","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.3233\/JAD-170187_ref52","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00259-015-3231-2","article-title":"Tau imaging in neurodegenerative diseases","volume":"43","author":"Dani","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-170187_ref53","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fneur.2015.00038","article-title":"PET imaging of tau pathology in Alzheimer\u2019s disease and tauopathies","volume":"6","author":"James","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-170187_ref55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cca.2015.01.041","article-title":"Alzheimer\u2019s disease - recent biomarker developments in relation to updated diagnostic criteria","volume":"449","author":"Hoglund","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-170187_ref56","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-150238","article-title":"Alzheimer\u2019s disease cerebrospinal fluid and neuroimaging biomarkers: Diagnostic accuracy and relationship to drug efficacy","volume":"46","author":"Khan","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fneur.2015.00138","article-title":"Cerebrospinal fluid p-tau181P: Biomarker for improved differential dementia diagnosis","volume":"6","author":"Struyfs","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-170187_ref58","first-page":"1","article-title":"Csf p-tau\/tau ratio as biomarker for TDP pathology in frontotemporal dementia","volume":"16","author":"Borroni","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.3233\/JAD-170187_ref59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-140267","article-title":"Cerebrospinal fluid levels of a 20-22 kDa NH2 fragment of human tau provide a novel neuronal injury biomarker in Alzheimer\u2019s disease and other dementias","volume":"42","author":"Amadoro","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2011-101641","article-title":"Human platelets tau: A potential peripheral marker for Alzheimer\u2019s disease","volume":"25","author":"Neumann","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/SMJ.0000000000000086","article-title":"Serum biomarkers for traumatic brain injury","volume":"107","author":"Neher","year":"2014","journal-title":"South Med J"},{"key":"10.3233\/JAD-170187_ref62","doi-asserted-by":"crossref","first-page":"P654","DOI":"10.1016\/j.jalz.2014.05.1162","article-title":"Validation of a caspase-3 generated tau fragment as a serum biomarker of brain damage due to stroke: Implications for Alzheimer\u2019s disease","volume":"10","author":"Inekci","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170187_ref63","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1089\/neu.2014.3741","article-title":"Serum tau fragments predict return to play in concussed professional ice hockey players","volume":"33","author":"Shahim","year":"2015","journal-title":"J Neurotrauma"},{"key":"10.3233\/JAD-170187_ref64","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-170187_ref65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/02699052.2012.750752","article-title":"Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma","volume":"27","author":"Neselius","year":"2013","journal-title":"Brain Inj"},{"key":"10.3233\/JAD-170187_ref66","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3233\/JAD-140756","article-title":"Circulating miRNAs as potential biomarkers in Alzheimer\u2019s disease","volume":"42","author":"Galimberti","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2014.03.016","article-title":"Phosphorylation of protein Tau by GSK3\u03b2 prolongs survival of bigenic Tau. P301L\u00d7GSK3\u03b2 mice by delaying brainstem tauopathy","volume":"67","author":"Crespo-Biel","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-170187_ref68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jnc.12769","article-title":"Ionizing radiation causes increased tau phosphorylation in primary neurons","volume":"131","author":"Li","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170187_ref69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nan.12084","article-title":"Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer\u2019s disease and Down syndrome","volume":"40","author":"Mondragon-Rodriguez","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-170187_ref70","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00401-013-1188-4","article-title":"LRRK2 phosphorylates novel tau epitopes and promotes tauopathy","volume":"126","author":"Bailey","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref71","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1073\/pnas.1322614111","article-title":"Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam","volume":"111","author":"Arif","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.3233\/JAD-170187_ref72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.brainres.2013.11.004","article-title":"Hyperphosphorylation of tau protein in the ipsilateral thalamus after focal cortical infarction in rats","volume":"1543","author":"Dong","year":"2014","journal-title":"Brain Res"},{"key":"10.3233\/JAD-170187_ref73","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.redox.2014.03.002","article-title":"Abeta and tau toxicities in Alzheimer\u2019s are linked via oxidative stress-induced p38 activation: Protective role of vitamin E","volume":"2","author":"Giraldo","year":"2014","journal-title":"Redox Biol"},{"key":"10.3233\/JAD-170187_ref74","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JAD-131529","article-title":"Alzheimer\u2019s disease and methanol toxicity (part 1): Chronic methanol feeding led to memory impairments and tau hyperphosphorylation in mice","volume":"41","author":"Yang","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref75","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/acel.12565","article-title":"Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model","volume":"16","author":"Bodea","year":"2017","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-170187_ref76","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/ane.12644","article-title":"Involvement of tau phosphorylation in traumatic brain injury patients","volume":"135","author":"Yang","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-170187_ref77","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/srep00480","article-title":"Hypothermia-induced hyperphosphorylation: A new model to study tau kinase inhibitors","volume":"2","author":"Bretteville","year":"2012","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-170187_ref78","first-page":"3173","article-title":"Phosphorylation of tau protein over time in rats subjected to transient brain ischemia","volume":"8","author":"Song","year":"2013","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-170187_ref79","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1177\/0271678X16668889","article-title":"Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer\u2019s disease - hyperphosphorylation and cleavage of 4- and 3-repeat tau","volume":"37","author":"Fujii","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-170187_ref80","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1093\/brain\/aww205","article-title":"Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss","volume":"139","author":"Tiwari","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroscience.2014.06.013","article-title":"MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer\u2019s disease","volume":"275","author":"Zhao","year":"2014","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-170187_ref82","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","article-title":"MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease","volume":"33","author":"Banzhaf-Strathmann","year":"2014","journal-title":"EMBO J"},{"key":"10.3233\/JAD-170187_ref83","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.15252\/emmm.201606520","article-title":"miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer\u2019s brain","volume":"8","author":"Salta","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-170187_ref84","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s12035-016-9858-6","article-title":"Targeted downregulation of dMyc suppresses pathogenesis of human neuronal tauopathies in drosophila by limiting heterochromatin relaxation and tau hyperphosphorylation","volume":"54","author":"Chanu","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-170187_ref85","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1016\/j.bmc.2014.09.032","article-title":"Phosphorylation regulates fibrillation of an aggregation core peptide in the second repeat of microtubule-binding domain of human tau","volume":"22","author":"Inoue","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.3233\/JAD-170187_ref86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.csbj.2014.09.011","article-title":"Cell-based models to investigate tau aggregation","volume":"12","author":"Lim","year":"2014","journal-title":"Comput Struct Biotechnol J"},{"key":"10.3233\/JAD-170187_ref87","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.bpj.2010.03.013","article-title":"The role of the lipid bilayer in tau aggregation","volume":"98","author":"Elbaum-Garfinkle","year":"2010","journal-title":"Biophys J"},{"key":"10.3233\/JAD-170187_ref88","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-170187_ref89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13024-015-0011-1","article-title":"Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology","volume":"10","author":"Song","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-170187_ref90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/alzrt259","article-title":"Acetylation: A new key to unlock tau\u2019s role in neurodegeneration","volume":"6","author":"Cook","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-170187_ref91","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/hmg\/dds125","article-title":"Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation","volume":"21","author":"Cook","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-170187_ref92","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nm.3951","article-title":"Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits","volume":"21","author":"Min","year":"2015","journal-title":"Nat Med"},{"key":"10.3233\/JAD-170187_ref93","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1523\/JNEUROSCI.1592-12.2012","article-title":"Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies","volume":"32","author":"Vanderweyde","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-170187_ref94","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2014.05.052","article-title":"Pathological stress granules in Alzheimer\u2019s disease","volume":"1584","author":"Ash","year":"2014","journal-title":"Brain Res"},{"key":"10.3233\/JAD-170187_ref95","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.febslet.2006.05.029","article-title":"Truncated tau from sporadic Alzheimer\u2019s disease suffices to drive neurofibrillary degeneration in vivo","volume":"580","author":"Zilka","year":"2006","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-170187_ref96","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/NEN.0b013e31817275c7","article-title":"Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease","volume":"67","author":"Basurto-Islas","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-170187_ref97","first-page":"33","article-title":"The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer\u2019s disease","volume":"9","author":"Flores-Rodriguez","year":"2015","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-170187_ref98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-170187_ref99","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2015.12.006","article-title":"Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model","volume":"87","author":"Kim","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-170187_ref100","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.18632\/oncotarget.7861","article-title":"Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial parkin","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"10.3233\/JAD-170187_ref101","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI78421","article-title":"Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau","volume":"125","author":"Santa-Maria","year":"2015","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-170187_ref102","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-150396","article-title":"Expression of tau produces aberrant plasma membrane blebbing in glial cells through RhoA-ROCK-dependent F-actin remodeling","volume":"52","author":"Torres-Cruz","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/B:MCBI.0000041848.57020.57","article-title":"Autophagy: Many paths to the same end","volume":"263","author":"Cuervo","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.3233\/JAD-170187_ref104","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neurobiolaging.2013.11.019","article-title":"Autophagy in aging and neurodegenerative diseases: Implications for pathogenesis and therapy","volume":"35","author":"Tan","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170187_ref105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.semcdb.2010.02.008","article-title":"Autophagy, a guardian against neurodegeneration","volume":"21","author":"Garc\u00eda-Arencibia","year":"2010","journal-title":"Semin Cell Dev Biol"},{"key":"10.3233\/JAD-170187_ref106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","article-title":"Tau degradation: The ubiquitin\u2013proteasome system versus the autophagy-lysosome system","volume":"105","author":"Lee","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-170187_ref107","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ceb.2009.12.004","article-title":"The role of the Atg1\/ULK1 complex in autophagy regulation","volume":"22","author":"Mizushima","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.3233\/JAD-170187_ref108","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1128\/MCB.01344-09","article-title":"Tor directly controls the Atg1 kinase complex to regulate autophagy","volume":"30","author":"Kamada","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.3233\/JAD-170187_ref109","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-013-8505-8","article-title":"Targeting the mTOR signaling network for Alzheimer\u2019s disease therapy","volume":"49","author":"Wang","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-170187_ref110","doi-asserted-by":"crossref","first-page":"P189","DOI":"10.1016\/j.jalz.2013.05.327","article-title":"The role of autophagy in Alzheimer\u2019s disease","volume":"9","author":"Orr","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170187_ref111","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12031-015-0692-5","article-title":"NPAS4 facilitates the autophagic clearance of endogenous tau in rat cortical neurons","volume":"58","author":"Fan","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-170187_ref112","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbagrm.2010.07.006","article-title":"Role of ubiquitin\u2013proteasome-mediated proteolysis in nervous system disease","volume":"1809","author":"Hegde","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-170187_ref113","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.bbadis.2014.05.029","article-title":"Axotrophin\/MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein in vitro impairing microtubule binding","volume":"1842","author":"Flach","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-170187_ref114","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.celrep.2012.07.013","article-title":"Role of S5b\/PSMD5 in proteasome inhibition caused by TNF-\u03b1\/NF\u03baB in higher eukaryotes","volume":"2","author":"Shim Sang","year":"2012","journal-title":"Cell Rep"},{"key":"10.3233\/JAD-170187_ref115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2010.06732.x","article-title":"Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing","volume":"114","author":"Suh","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170187_ref116","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1242\/jcs.03438","article-title":"Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease","volume":"120","author":"van Tijn","year":"2007","journal-title":"J\u00a0Cell Sci"},{"key":"10.3233\/JAD-170187_ref117","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-170187_ref118","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2012.05.021","article-title":"Constitutive secretion of tau protein by an unconventional mechanism","volume":"48","author":"Chai","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-170187_ref119","doi-asserted-by":"crossref","first-page":"42751","DOI":"10.1074\/jbc.M112.380642","article-title":"Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies","volume":"287","author":"Karch","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170187_ref120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/embor.2013.15","article-title":"Physiological release of endogenous tau is stimulated by neuronal activity","volume":"14","author":"Pooler","year":"2013","journal-title":"EMBO Rep"},{"key":"10.3233\/JAD-170187_ref121","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/jnc.12991","article-title":"Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer\u2019s disease","volume":"133","author":"Sokolow","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170187_ref122","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12640-017-9765-2","article-title":"Spreading of pathology in Alzheimer\u2019s disease","volume":"32","author":"Lv","year":"2017","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-170187_ref123","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","article-title":"Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170187_ref124","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.mcn.2007.12.010","article-title":"Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells","volume":"37","author":"Gomez-Ramos","year":"2008","journal-title":"Mol Cell Neurosci"},{"issue":"Suppl 1","key":"10.3233\/JAD-170187_ref125","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3233\/JAD-131832","article-title":"Sources of extracellular tau and its signaling","volume":"40","author":"Avila","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref126","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","article-title":"Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons","volume":"288","author":"Wu","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170187_ref127","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1038\/ncomms9490","article-title":"Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer\u2019s disease brain","volume":"6","author":"Takeda","year":"2015","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-170187_ref128","doi-asserted-by":"crossref","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","article-title":"Trans-synaptic spread of tau pathology in vivo","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170187_ref129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nan.12197","article-title":"Invited review: Prion-like transmission and spreading of tau pathology","volume":"41","author":"Clavaguera","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-170187_ref130","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-170187_ref131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","article-title":"Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease","volume":"3","author":"Pooler","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-170187_ref132","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nan.12200","article-title":"Invited review: Animal models of tauopathies and their implications for research\/translation into the clinic","volume":"41","author":"Dujardin","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-170187_ref133","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1073\/pnas.1533448100","article-title":"Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy","volume":"100","author":"Kraemer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-170187_ref134","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/hmg\/dds190","article-title":"Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity","volume":"21","author":"Fatouros","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-170187_ref135","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3233\/JAD-142802","article-title":"Drosophila models of Alzheimer\u2019s disease: Advances, limits, and perspectives","volume":"45","author":"Bouleau","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref136","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-007-0291-9","article-title":"Tauopathy models and human neuropathology: Similarities and differences","volume":"115","author":"Frank","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref137","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.expneurol.2008.03.007","article-title":"A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics","volume":"212","author":"Rosenmann","year":"2008","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-170187_ref138","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/156720511796717230","article-title":"Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: What links with tau pathology?","volume":"8","author":"Belarbi","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-170187_ref139","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2012.07.001","article-title":"Tau as a therapeutic target in neurodegenerative disease","volume":"136","author":"Himmelstein","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.3233\/JAD-170187_ref140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainresbull.2011.03.006","article-title":"Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways","volume":"85","author":"Hu","year":"2011","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-170187_ref141","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12031-015-0519-4","article-title":"Escitalopram ameliorates forskolin-induced tau hyperphosphorylation in HEK239\/tau441 cells","volume":"56","author":"Ren","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-170187_ref142","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/jbc.M111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase kinase-3beta by tideglusib","volume":"287","author":"Dominguez","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170187_ref143","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: The story so far","volume":"12","author":"Iqbal","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-170187_ref144","doi-asserted-by":"crossref","first-page":"13328","DOI":"10.18632\/oncotarget.7798","article-title":"Escitalopram attenuates beta-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt\/GSK-3beta pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.3233\/JAD-170187_ref145","doi-asserted-by":"crossref","first-page":"13888","DOI":"10.1073\/pnas.1009038107","article-title":"Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer\u2019s disease models","volume":"107","author":"van Eersel","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-170187_ref146","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bbamcr.2013.02.005","article-title":"PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B","volume":"1833","author":"Luo","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-170187_ref147","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp-2012-303144","article-title":"Therapeutic strategies for tau mediated neurodegeneration","volume":"84","author":"Yoshiyama","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-170187_ref148","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12603-014-0514-4","article-title":"Folic Acid Inhibits Tau Phosphorylation through Regulation of PP2A Methylation in SH-SY5Y Cells","volume":"19","author":"Li","year":"2015","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-170187_ref149","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1038\/cddis.2012.187","article-title":"Anthraquinone-2-sulfonic acid (AQ2S) is a novel neurotherapeutic agent","volume":"4","author":"Jackson","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.3233\/JAD-170187_ref150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4161\/auto.19048","article-title":"Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo","volume":"8","author":"Congdon","year":"2012","journal-title":"Autophagy"},{"key":"10.3233\/JAD-170187_ref151","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","article-title":"Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease","volume":"88","author":"Wischik","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-170187_ref152","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bcp.2014.01.013","article-title":"New perspectives on the role of tau in Alzheimer\u2019s disease. Implications for therapy","volume":"88","author":"Medina","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-170187_ref153","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00401-015-1483-3","article-title":"Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies","volume":"130","author":"Wagner","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170187_ref154","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.neuint.2011.02.010","article-title":"Oleuropein and derivatives from olives as Tau aggregation inhibitors","volume":"58","author":"Daccache","year":"2011","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-170187_ref155","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.neurobiolaging.2011.09.027","article-title":"GSPE interferes with tau aggregation in vivo: Implication for treating tauopathy","volume":"33","author":"Santa-Maria","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170187_ref156","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jmb.2014.01.004","article-title":"O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers","volume":"426","author":"Yuzwa","year":"2014","journal-title":"J Mol Biol"},{"key":"10.3233\/JAD-170187_ref157","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1523\/JNEUROSCI.4922-11.2012","article-title":"The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice","volume":"32","author":"Zhang","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-170187_ref158","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jnr.23394","article-title":"Effect of taxoid and nontaxoid site microtubule-stabilizing agents on axonal transport of mitochondria in untransfected and ECFP-htau40-transfected rat cortical neurons in culture","volume":"92","author":"Das","year":"2014","journal-title":"J Neurosci Res"},{"issue":"Suppl 1","key":"10.3233\/JAD-170187_ref159","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3233\/JAD-131664","article-title":"Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide)","volume":"40","author":"Gozes","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-170187_ref160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-013-0103-8","article-title":"NAP alpha-aminoisobutyric acid (IsoNAP)","volume":"52","author":"Gozes","year":"2014","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-170187_ref161","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bcp.2013.12.020","article-title":"Immunotherapy for Alzheimer\u2019s disease","volume":"88","author":"Wisniewski","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-170187_ref162","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720512800492503","article-title":"Targeting phospho-Ser422 by active Tau immunotherapy in the THYTau22 mouse model: A suitable therapeutic approach","volume":"9","author":"Troquier","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-170187_ref163","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/nan.12192","article-title":"Invited review: Drug development for tauopathies","volume":"41","author":"Gruninger","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-170187_ref164","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-170187_ref165","doi-asserted-by":"crossref","first-page":"e72301","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau. P301L mice that model tauopathy","volume":"8","author":"Theunis","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170187_ref166","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","article-title":"Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo","volume":"80","author":"Yanamandra","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-170187_ref167","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2014.05.047","article-title":"p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice","volume":"575","author":"Walls","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-170187_ref168","first-page":"135","article-title":"Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice","volume":"135","author":"Ittner","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170187_ref169","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awu213","article-title":"Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2019s disease","volume":"137","author":"Collin","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref170","doi-asserted-by":"crossref","first-page":"e62402","DOI":"10.1371\/journal.pone.0062402","article-title":"Tau passive immunotherapy in mutant P301L mice: Antibody affinity versus specificity","volume":"8","author":"d\u2019Abramo","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170187_ref171","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/acn3.176","article-title":"Anti-tau antibody reduces insoluble tau and decreases brain atrophy","volume":"2","author":"Yanamandra","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-170187_ref172","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/acn3.171","article-title":"Passive immunotherapy of tauopathy targeting pSer413-tau: A pilot study in mice","volume":"2","author":"Umeda","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-170187_ref173","doi-asserted-by":"crossref","first-page":"e0125614","DOI":"10.1371\/journal.pone.0125614","article-title":"Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models","volume":"10","author":"Sankaranarayanan","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170187_ref174","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4179","article-title":"Neurodegenerative disease: Tau immunotherapy targets transcellular propagation","volume":"12","author":"Flight","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-170187_ref175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/alzrt277","article-title":"Identification of structural determinants on tau protein essential for its pathological function: Novel therapeutic target for tau immunotherapy in Alzheimer\u2019s disease","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"Pt 5","key":"10.3233\/JAD-170187_ref176","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/brain\/aww036","article-title":"A subcutaneous cellular implant for passive immunization against amyloid-beta reduces brain amyloid and tau pathologies","volume":"139","author":"Lathuiliere","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref177","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tips.2014.09.002","article-title":"Targeting autophagy in neurodegenerative diseases","volume":"35","author":"Vidal","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-170187_ref178","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2014.05.032","article-title":"Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance","volume":"85","author":"Jiang","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-170187_ref179","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/brain\/aws143","article-title":"Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy","volume":"135","author":"Schaeffer","year":"2012","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref180","doi-asserted-by":"crossref","first-page":"S483","DOI":"10.1016\/j.jalz.2011.05.1405","article-title":"Long-term oral lithium treatment attenuates motor disturbance by promoting autophagy in tauopathy model mice","volume":"7","author":"Shimada","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170187_ref181","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00207454.2012.729234","article-title":"Therapeutic effects of valproate combined with lithium carbonate on MPTP-induced parkinsonism in mice: Possible mediation through enhanced autophagy","volume":"123","author":"Li","year":"2013","journal-title":"Int J Neurosci"},{"key":"10.3233\/JAD-170187_ref182","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1567205011310040008","article-title":"Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-beta pathology in a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Li","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-170187_ref183","doi-asserted-by":"crossref","first-page":"P476","DOI":"10.1016\/j.jalz.2014.05.691","article-title":"Sulforaphane promotes the degradation of phosphorylated tau via the induction of autophagy","volume":"10","author":"Cho","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170187_ref184","doi-asserted-by":"crossref","first-page":"P636","DOI":"10.1016\/j.jalz.2012.05.1697","article-title":"Interaction between the ubiquitin proteasome system, autophagy and progressive tauopathy in vivo","volume":"8","author":"Myeku","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170187_ref185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","article-title":"Enhancement of proteasome activity by a small-molecule inhibitor of USP14","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"key":"10.3233\/JAD-170187_ref186","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddh083","article-title":"CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation","volume":"13","author":"Petrucelli","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-170187_ref187","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat Med"},{"key":"10.3233\/JAD-170187_ref188","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awv081","article-title":"Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain","volume":"138","author":"Maphis","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref189","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/brain\/awt323","article-title":"Fractalkine activates NRF2\/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis","volume":"137","author":"Lastres-Becker","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-170187_ref190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-170187_ref191","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12974-014-0147-x","article-title":"SCM-198 inhibits microglial overactivation and attenuates Abeta(1-40)-induced cognitive impairments in rats via JNK and NF-small ka, CyrillicB pathways","volume":"11","author":"Hong","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-170187_ref192","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1073\/pnas.0914957107","article-title":"A role for FKBP52 in Tau protein function","volume":"107","author":"Chambraud","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:19Z","timestamp":1777370719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":192,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-170187","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]}}}